Margaretha HaeusslerExecutive Director, Transfer Pricing at NOVARTIS
Agenda Sessions
Amount B/Simplified and Streamlined Approach – Global Roundup & Status Update
, 1:20pmView SessionSuccessful Approaches to Valuation of IP
, 3:10pmView Session